메뉴 건너뛰기




Volumn 27, Issue SUPPL. 2, 2011, Pages 53-62

Treatment outcomes with methylphenidate formulations among patients with ADHD: Retrospective claims analysis of a managed care population

Author keywords

ADHD; Claims database; Managed care; Methylphenidate; Real world study; Treatment patterns

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CLONIDINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE;

EID: 80053607875     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.623158     Document Type: Article
Times cited : (38)

References (43)
  • 1
    • 38949187920 scopus 로고    scopus 로고
    • Pharmacologic treatment of ADHD: Road conditions in driving patients to successful outcomes
    • Manos MJ. Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes. Medscape J Med 2008;8:10:5
    • (2008) Medscape J Med , vol.8 , Issue.10 , pp. 5
    • Manos, M.J.1
  • 2
    • 0034963296 scopus 로고    scopus 로고
    • Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder
    • DOI 10.1542/peds.108.1.71
    • Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:71-8 (Pubitemid 32592007)
    • (2001) Pediatrics , vol.108 , Issue.1 , pp. 71-78
    • Guevara, J.1    Lozano, P.2    Wickizer, T.3    Mell, L.4    Gephart, H.5
  • 4
    • 79957692249 scopus 로고    scopus 로고
    • Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans
    • Hodgkins P, Montejano L Sasané R, et al. Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans. Primary Care Companion 2011;13:e1-e12
    • (2011) Primary Care Companion , vol.13
    • Hodgkins, P.1    Montejano, L.2    Sasané, R.3
  • 5
    • 1642514265 scopus 로고    scopus 로고
    • The worldwide prevalence of ADHD: Is it an American condition?
    • Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104-13
    • (2003) World Psychiatry , vol.2 , pp. 104-113
    • Faraone, S.V.1    Sergeant, J.2    Gillberg, C.3
  • 6
    • 22144455050 scopus 로고    scopus 로고
    • Attention-deficit hyperactivity disorder
    • DOI 10.1016/S0140-6736(05)66915-2, PII S0140673605669152
    • Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-48 (Pubitemid 40981053)
    • (2005) Lancet , vol.366 , Issue.9481 , pp. 237-248
    • Biederman, J.1    Faraone, S.V.2
  • 7
    • 37548998944 scopus 로고    scopus 로고
    • Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder
    • Purper-Ouakil D, Cortese S, Wohl M, et al. Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2007;16:505-9
    • (2007) Eur Child Adolesc Psychiatry , vol.16 , pp. 505-509
    • Purper-Ouakil, D.1    Cortese, S.2    Wohl, M.3
  • 9
    • 54249133889 scopus 로고    scopus 로고
    • Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic achievement
    • Powers RL, Marks DJ, Miller CJ, et al. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic achievement. J Child Adolesc Psychopharmacol 2008;18:449-59
    • (2008) J Child Adolesc Psychopharmacol , vol.18 , pp. 449-459
    • Powers, R.L.1    Marks, D.J.2    Miller, C.J.3
  • 10
    • 66049093064 scopus 로고    scopus 로고
    • Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school
    • Scheffler RM, Brown TT, Fulton BD, et al. Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 2009;123:1273-9
    • (2009) Pediatrics , vol.123 , pp. 1273-1279
    • Scheffler, R.M.1    Brown, T.T.2    Fulton, B.D.3
  • 11
    • 3042622074 scopus 로고    scopus 로고
    • Clinical practice guideline: Treatment of the school-age child with attention-deficit/hyperactivity disorder
    • American Academy of Pediatrics
    • American Academy of Pediatrics. Clinical practice guideline: treatment of the school-age child with attention-deficit/hyperactivity disorder. Pediatrics 2001;4:1033-44
    • (2001) Pediatrics , vol.4 , pp. 1033-1044
  • 12
    • 70350768832 scopus 로고    scopus 로고
    • Canadian Attention Deficit Hyperactivity Disorder Resource Alliance [CADDRA] [Last accessed November 2009]
    • Canadian Attention Deficit Hyperactivity Disorder Resource Alliance [CADDRA]. Canadian ADHD Practice Guidelines. Available at: http://www.caddra.ca/ cms4/index.php?optioncom-content&viewarticle&id 26&Itemid353& langen [Last accessed November 2009]
    • Canadian ADHD Practice Guidelines
  • 13
    • 52649104413 scopus 로고    scopus 로고
    • Diagnosis and management of attentiondeficit/hyperactivity disorder in children, young people, adults: Summary of NICE guidance
    • Kendall T, Taylor E, Perez A, et al. Diagnosis and management of attentiondeficit/hyperactivity disorder in children, young people, adults: summary of NICE guidance. BMJ 2008;337:a1239
    • (2008) BMJ , vol.337
    • Kendall, T.1    Taylor, E.2    Perez, A.3
  • 14
    • 34250797891 scopus 로고    scopus 로고
    • Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
    • AACAP Work Group on Quality Issues
    • Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-21
    • (2007) J Am Acad Child Adolesc Psychiatry , vol.46 , pp. 894-821
    • Pliszka, S.1
  • 15
    • 27744601191 scopus 로고    scopus 로고
    • Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence
    • DOI 10.1542/peds.2004-2560
    • Brown RT, Amler RW, Freeman WS, et al.; American Academy of Pediatrics Committee on Quality Improvement. American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/ hyperactivity disorder: overview of the evidence. Pediatrics 2005;115:e749-e757 (Pubitemid 43843150)
    • (2005) Pediatrics , vol.115 , Issue.6
    • Brown, R.T.1    Amler, R.W.2    Freeman, W.S.3    Perrin, J.M.4    Stein, M.T.5    Feldman, H.M.6    Pierce, K.7    Wolraich, M.L.8
  • 16
    • 70449120823 scopus 로고    scopus 로고
    • Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder
    • Spencer TJ, Greenbaum M, Ginsberg LD, et al. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:501-10
    • (2009) J Child Adolesc Psychopharmacol , vol.19 , pp. 501-510
    • Spencer, T.J.1    Greenbaum, M.2    Ginsberg, L.D.3
  • 17
    • 78651479969 scopus 로고    scopus 로고
    • Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder
    • Jair R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011;50:171-9
    • (2011) J Am Acad Child Adolesc Psychiatry , vol.50 , pp. 171-179
    • Jair, R.1    Segal, S.2    Kollins, S.H.3
  • 18
    • 77950350304 scopus 로고    scopus 로고
    • The quality of life of children with attention deficit/hyperactivity disorder: A systematic review
    • Danckaerts M, Sonuga-Barke EJ, Banaschewski T, et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 2010;19:83-105
    • (2010) Eur Child Adolesc Psychiatry , vol.19 , pp. 83-105
    • Danckaerts, M.1    Sonuga-Barke, E.J.2    Banaschewski, T.3
  • 19
    • 33748656471 scopus 로고    scopus 로고
    • Effectiveness outcomes in attentiondeficit/hyperactivity disorder
    • Weiss MD, Gadow K, Wasdell MB, et al. Effectiveness outcomes in attentiondeficit/hyperactivity disorder. J Clin Psychiatry 2006;67(Suppl 8):38-45
    • (2006) J Clin Psychiatry , vol.67 , Issue.SUPPL. 8 , pp. 38-45
    • Weiss, M.D.1    Gadow, K.2    Wasdell, M.B.3
  • 20
    • 70349285147 scopus 로고    scopus 로고
    • The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness
    • Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(Suppl 4):1-46
    • (2009) J Clin Psychiatry , vol.70 , Issue.SUPPL. 4 , pp. 1-46
    • Velligan, D.I.1    Weiden, P.J.2    Sajatovic, M.3
  • 21
    • 3242749792 scopus 로고    scopus 로고
    • Satisfaction with treatment for attention-deficit/hyperactivity disorder
    • Buckstein OG. Satisfaction with treatment for attention-deficit/ hyperactivity disorder. Am J Manag Care 2004;10:S107-16
    • (2004) Am J Manag Care , vol.10
    • Buckstein, O.G.1
  • 22
    • 73249133383 scopus 로고    scopus 로고
    • Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
    • Buckstein OG, Arnold LE, Landgraf JM, et al. Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? Child Adolesc Psych Mental Health 2009;2:39
    • (2009) Child Adolesc Psych Mental Health , vol.2 , pp. 39
    • Buckstein, O.G.1    Arnold, L.E.2    Landgraf, J.M.3
  • 23
    • 77958551382 scopus 로고    scopus 로고
    • Time course and predictors of healthrelated quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/ hyperactivity disorder treatment with the methylphenidate transdermal system
    • Frazier TW, Weiss M, Hodgkins P, et al. Time course and predictors of healthrelated quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treatment with the methylphenidate transdermal system. J Child Adolesc Psychopharmacol 2010;20:355-64
    • (2010) J Child Adolesc Psychopharmacol , vol.20 , pp. 355-364
    • Frazier, T.W.1    Weiss, M.2    Hodgkins, P.3
  • 24
    • 72549111730 scopus 로고    scopus 로고
    • HRQL and medication satisfaction in children with ADHD treatment with the methylphenidate transdermal system
    • Manos M, Frazier TW, Landgraf JM, et al. HRQL and medication satisfaction in children with ADHD treatment with the methylphenidate transdermal system. CMRO 2009;25:3001-10
    • (2009) CMRO , vol.25 , pp. 3001-3010
    • Manos, M.1    Frazier, T.W.2    Landgraf, J.M.3
  • 25
    • 77951081496 scopus 로고    scopus 로고
    • Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder
    • Weiss MD, Gibbins C, Goodman DW, et al. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psych 2010;71:381-90
    • (2010) J Clin Psych , vol.71 , pp. 381-390
    • Weiss, M.D.1    Gibbins, C.2    Goodman, D.W.3
  • 26
    • 84884350750 scopus 로고    scopus 로고
    • Attention deficit hyperactivity disorder
    • National Institute for Health and Clinical Excellence NICE [Last accessed 22 Sep 2011]
    • National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder. NICE clinical guideline 72. NICE, 2008. Available at: http://guidance.nice.org.uk/CG72/NICEGuidance/pdf/English [Last accessed 22 Sep 2011]
    • (2008) NICE Clinical Guideline 72
  • 27
    • 33845794758 scopus 로고    scopus 로고
    • Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study
    • ADORE Study Group
    • Preuss U, Ralston SJ, Baldursson G, et al. ADORE Study Group. Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 2006;15(Suppl 1):14-14
    • (2006) Eur Child Adolesc Psychiatry , vol.15 , Issue.SUPPL. 1 , pp. 14-14
    • Preuss, U.1    Ralston, S.J.2    Baldursson, G.3
  • 28
    • 34548023694 scopus 로고    scopus 로고
    • The economic impact of attention-deficit/hyperactivity disorder in children and adolescents
    • DOI 10.1093/jpepsy/jsm022
    • Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 2007;32:711-27 (Pubitemid 47356048)
    • (2007) Journal of Pediatric Psychology , vol.32 , Issue.6 , pp. 711-727
    • Pelham, W.E.1    Foster, E.M.2    Robb, J.A.3
  • 29
    • 77949497812 scopus 로고    scopus 로고
    • Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: Retrospective claims-based analysis of a managed care population
    • Christensen L, Sasané R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-89
    • (2010) Curr Med Res Opin , vol.26 , pp. 977-989
    • Christensen, L.1    Sasané, R.2    Hodgkins, P.3
  • 30
    • 0031427407 scopus 로고    scopus 로고
    • Variations in compliance among hypertensive patients by drug class: Implications for health care costs
    • DOI 10.1016/S0149-2918(97)80018-5
    • Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997;19:1446-57 (Pubitemid 28133280)
    • (1997) Clinical Therapeutics , vol.19 , Issue.6 , pp. 1446-1457
    • Rizzo, J.A.1    Simons, W.R.2
  • 31
    • 0025282371 scopus 로고
    • Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation
    • Barkley RA, McMurray MB, Edelbrock CS, et al. Side effects of methylphenidate in children with attention deficit hyperactivity disorder. A systematic, placebo-controlled evaluation. Paediatrics 1990;86:184-92 (Pubitemid 20238848)
    • (1990) Pediatrics , vol.86 , Issue.2 , pp. 184-192
    • Barkley, R.A.1    McMurray, M.B.2    Edelbrock, C.S.3    Robbins, K.4
  • 33
    • 4444352968 scopus 로고    scopus 로고
    • European clinical guidelines for hyperkinetic disorder-first upgrade
    • Taylor E, Dopfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 2004;13(Suppl 1):17-30
    • (2004) Eur Child Adolesc Psychiatry , vol.13 , Issue.SUPPL. 1 , pp. 17-30
    • Taylor, E.1    Dopfner, M.2    Sergeant, J.3
  • 34
    • 58249144114 scopus 로고    scopus 로고
    • Stimulant dosing for children with ADHD: A medical claims analysis
    • Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Adolesc Psychiatry 2009; 48:51-9
    • (2009) J Am Acad Child Adolesc Psychiatry , vol.48 , pp. 51-59
    • Olfson, M.1    Marcus, S.2    Wan, G.3
  • 36
    • 35848947225 scopus 로고    scopus 로고
    • Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS)
    • Vitiello B, Abikoff HB, Chuang SZ, et al. Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmcol 2007;17:593-604
    • (2007) J Child Adolesc Psychopharmcol , vol.17 , pp. 593-604
    • Vitiello, B.1    Abikoff, H.B.2    Chuang, S.Z.3
  • 37
    • 2342599689 scopus 로고    scopus 로고
    • Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder
    • Perwein AR, Hall J, Swensen A, et al. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/ hyperactivity disorder. JMCP 2004;10:122-9
    • (2004) JMCP , vol.10 , pp. 122-129
    • Perwein, A.R.1    Hall, J.2    Swensen, A.3
  • 38
    • 67650308856 scopus 로고    scopus 로고
    • Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment
    • Pappadopulos E, Jensen PS, Chait AR, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 2009;48:501-10
    • (2009) J Am Acad Child Adolesc Psychiatry , vol.48 , pp. 501-510
    • Pappadopulos, E.1    Jensen, P.S.2    Chait, A.R.3
  • 39
    • 21444440571 scopus 로고    scopus 로고
    • Assessment of adherence measures with different stimulants among children and adolescents
    • DOI 10.1592/phco.2005.25.7.909
    • Sanchez RJ, Crismon ML, Barner JC, et al. Assessment of adherence measures with difference stimulants among children and adolescents. Pharmacotherapy 2005;25:909-17 (Pubitemid 40917923)
    • (2005) Pharmacotherapy , vol.25 , Issue.7 , pp. 909-917
    • Sanchez, R.J.1    Crismon, M.L.2    Barner, J.C.3    Bettinger, T.4    Wilson, J.P.5
  • 41
    • 0033950999 scopus 로고    scopus 로고
    • Predicting medication noncompliance after hospital discharge among patients with schizophrenia
    • DOI 10.1176/appi.ps.51.2.216
    • Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51:216-22 (Pubitemid 30082525)
    • (2000) Psychiatric Services , vol.51 , Issue.2 , pp. 216-222
    • Olfson, M.1    Mechanic, D.2    Hansell, S.3    Boyer, C.A.4    Walkup, J.5    Weiden, P.J.6
  • 42
    • 0000822363 scopus 로고    scopus 로고
    • Methylphenidate vs. amphetamine: Comparative review
    • Arnold LE. Methylphenidate vs. amphetamine: comparative review. J Attention Disord 2000;4:200-11
    • (2000) J Attention Disord , vol.4 , pp. 200-211
    • Arnold, L.E.1
  • 43
    • 0036080212 scopus 로고    scopus 로고
    • Efficacy of adderall and methylphenidate in attention deficit hyperactivity disorder: A drug-placebo and drug-drug response curve analysis of a naturalistic study
    • DOI 10.1017/S1461145702002845
    • Faraone SV, Short EJ, Biederman J, et al. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol 2002;5:121-9 (Pubitemid 34662974)
    • (2002) International Journal of Neuropsychopharmacology , vol.5 , Issue.2 , pp. 121-129
    • Faraone, S.V.1    Short, E.J.2    Biederman, J.3    Findling, R.L.4    Roe, C.5    Manos, M.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.